Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Array Technologies, Inc. Stock Price (Quote) NASDAQ:ARRY
$17.92 ( -5.93% ) Friday, 22nd Oct 2021
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $16.41 | $21.01 | Friday, 22nd Oct 2021 ARRY stock ended at $17.92. This is 5.93% less than the trading day before Thursday, 21st Oct 2021. During the day the stock fluctuated 7.64% from a day low at $17.66 to a day high of $19.01. |
| 90 days | $12.72 | $21.01 | |
| 52 weeks | $12.72 | $54.78 |
Historical Array Technologies, Inc. prices
| Date | Open | High | Low | Close | Volume |
| 2021-10-22 | $19.00 | $19.01 | $17.66 | $17.92 | 2 781 348 |
| 2021-10-21 | $18.61 | $19.25 | $18.61 | $19.05 | 2 247 327 |
| 2021-10-20 | $18.92 | $19.48 | $18.35 | $18.66 | 5 504 241 |
| 2021-10-19 | $19.59 | $21.01 | $19.41 | $20.41 | 3 645 325 |
| 2021-10-18 | $18.56 | $19.55 | $18.41 | $19.41 | 1 814 217 |
| 2021-10-15 | $20.24 | $20.24 | $18.85 | $18.87 | 8 667 859 |
| 2021-10-14 | $20.14 | $20.29 | $19.00 | $20.00 | 2 141 994 |
| 2021-10-13 | $19.97 | $20.11 | $19.23 | $19.95 | 2 038 754 |
| 2021-10-12 | $19.30 | $19.96 | $19.26 | $19.91 | 2 365 862 |
| 2021-10-11 | $18.68 | $19.91 | $18.68 | $19.17 | 3 783 888 |
| 2021-10-08 | $18.17 | $19.00 | $18.17 | $18.39 | 2 600 140 |
| 2021-10-07 | $17.33 | $19.00 | $17.21 | $18.17 | 2 365 619 |
| 2021-10-06 | $16.67 | $17.17 | $16.41 | $17.05 | 1 176 733 |
| 2021-10-05 | $16.80 | $17.10 | $16.65 | $16.88 | 1 310 371 |
| 2021-10-04 | $17.97 | $17.97 | $16.56 | $16.80 | 2 638 281 |
| 2021-10-01 | $18.55 | $18.70 | $18.08 | $18.10 | 1 888 211 |
| 2021-09-30 | $17.91 | $18.88 | $17.89 | $18.52 | 2 342 622 |
| 2021-09-29 | $17.81 | $18.10 | $17.25 | $17.65 | 2 549 817 |
| 2021-09-28 | $18.00 | $18.02 | $17.53 | $17.62 | 1 513 434 |
| 2021-09-27 | $17.45 | $18.38 | $16.95 | $18.12 | 1 758 295 |
| 2021-09-24 | $17.88 | $18.00 | $17.21 | $17.29 | 1 979 124 |
| 2021-09-23 | $18.21 | $18.27 | $17.58 | $18.01 | 2 750 760 |
| 2021-09-22 | $18.33 | $18.95 | $18.04 | $18.14 | 1 659 705 |
| 2021-09-21 | $17.68 | $18.23 | $17.43 | $18.13 | 2 411 714 |
| 2021-09-20 | $17.88 | $17.97 | $17.28 | $17.72 | 2 590 409 |
| 2021-09-17 | $18.19 | $18.51 | $17.81 | $18.50 | 2 941 047 |
| 2021-09-16 | $18.08 | $18.28 | $17.88 | $18.23 | 1 280 958 |
| 2021-09-15 | $18.42 | $18.48 | $17.69 | $18.12 | 2 026 056 |
| 2021-09-14 | $19.00 | $19.25 | $18.28 | $18.50 | 1 251 362 |
| 2021-09-13 | $17.60 | $19.23 | $17.46 | $19.00 | 2 782 055 |
| 2021-09-10 | $18.86 | $19.06 | $17.55 | $17.63 | 3 228 258 |
| 2021-09-09 | $18.65 | $19.08 | $18.41 | $18.85 | 1 821 710 |
| 2021-09-08 | $19.74 | $19.98 | $18.39 | $18.73 | 2 919 437 |
| 2021-09-07 | $19.20 | $20.43 | $19.19 | $19.72 | 2 439 700 |
| 2021-09-03 | $19.28 | $19.60 | $19.13 | $19.50 | 1 251 854 |
| 2021-09-02 | $19.11 | $19.99 | $19.07 | $19.36 | 2 304 940 |
| 2021-09-01 | $19.25 | $19.25 | $18.83 | $18.98 | 1 422 344 |
| 2021-08-31 | $19.05 | $19.48 | $18.90 | $19.07 | 2 148 485 |
| 2021-08-30 | $19.19 | $19.42 | $18.81 | $18.92 | 1 754 276 |
| 2021-08-27 | $19.06 | $19.61 | $18.91 | $19.32 | 1 752 797 |
| 2021-08-26 | $18.87 | $19.85 | $18.69 | $19.30 | 3 157 049 |
| 2021-08-25 | $18.95 | $19.12 | $18.45 | $18.58 | 2 249 676 |
| 2021-08-24 | $19.25 | $19.63 | $18.80 | $18.95 | 2 053 341 |
| 2021-08-23 | $18.37 | $19.59 | $18.25 | $19.26 | 3 050 456 |
| 2021-08-20 | $17.90 | $19.05 | $17.85 | $18.79 | 2 672 866 |
| 2021-08-19 | $18.80 | $18.82 | $17.50 | $17.99 | 4 618 734 |
| 2021-08-18 | $17.41 | $19.20 | $17.13 | $19.01 | 5 577 738 |
| 2021-08-17 | $16.90 | $17.59 | $16.90 | $17.38 | 3 700 082 |
| 2021-08-16 | $16.91 | $17.30 | $16.82 | $17.16 | 3 686 547 |
| 2021-08-13 | $16.93 | $17.60 | $16.91 | $17.31 | 4 479 415 |
Array BioPharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs to treat patients with cancer in North America, Europe, and the Asia Pacific. The companys drugs in Phase III clinical trials include Binimetinib, Encorafenib, and Selumetinib for the treatment of cancer, as well as ASC08/Danoprevir, a protease inhibitor for hepatitis C virus. Its drug candidates in Phase II cl... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Join 95.000+ Happy Subscribers
Don't miss out on the runners!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
